Concepedia

E. Marty

EM

Statistics

Publications

5

Citations

407

H-Index

5

Active since

1992

Affiliations

Sanofi (France)(Current)

E. Marty is an author at Sanofi (France) specializing in pharmacology, vasopressin receptor pharmacology, and vasopressin pharmacology.

Publications per year

1992–1996

5

Publications

5

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

C. Serradeil‐Le Gal, C Lacour, G Valette et al. · Journal of Clinical Investigation · 1996 · 249 citations · Full text

, , +11

Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells

C. Serradeil‐Le Gal, Jean‐Marc Herbert, Chantal Delisée et al. · American Journal of Physiology-Heart and Circulatory Physiology · 1995 · 53 citations

, , +15

Binding of (3H) SR 49059, a Potent Nonpeptide Vasopressin V1a Antagonist, to Rat and Human Liver Membranes

Danielle Raufaste, E. Marty, Corinne Garcia et al. · Biochemical and Biophysical Research Communications · 1994 · 40 citations

, , +7

Autoradiographic localization of vasopressin V1a receptors in the rat kidney using [3H]-SR 49059

Claudine Serradeil-Le Gal, Danielle Raufaste, E. Marty et al. · Kidney International · 1996 · 36 citations · Full text

, , +5

Plasma membrane Na(+)-H+ antiporter and H(+)-ATPase in the medullary thick ascending limb of rat kidney

Marc Froissart, Pascale Borensztein, Pascal Houillier et al. · American Journal of Physiology-Cell Physiology · 1992 · 29 citations

, , +16

1–5 of 5